Catalio Capital Management as of Dec. 31, 2025
Portfolio Holdings for Catalio Capital Management
Catalio Capital Management holds 45 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 6.3 | $36M | 289k | 122.74 | |
| Bristol Myers Squibb (BMY) | 6.2 | $35M | 648k | 53.94 | |
| Boston Scientific Corporation (BSX) | 6.1 | $34M | 360k | 95.35 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 5.6 | $31M | 411k | 76.49 | |
| Eli Lilly & Co. (LLY) | 4.9 | $28M | 26k | 1074.68 | |
| Dianthus Therapeutics (DNTH) | 4.8 | $27M | 654k | 41.21 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.5 | $25M | 119k | 213.24 | |
| Syndax Pharmaceuticals (SNDX) | 4.4 | $25M | 1.2M | 21.01 | |
| Johnson & Johnson (JNJ) | 4.4 | $25M | 121k | 206.95 | |
| Regeneron Pharmaceuticals (REGN) | 4.1 | $23M | 30k | 771.87 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.1 | $18M | 253k | 69.55 | |
| Soleno Therapeutics (SLNO) | 2.9 | $17M | 360k | 46.30 | |
| Cytokinetics Com New (CYTK) | 2.9 | $16M | 258k | 63.54 | |
| Edwards Lifesciences (EW) | 2.8 | $16M | 187k | 85.25 | |
| Intuitive Surgical Com New (ISRG) | 2.7 | $15M | 27k | 566.36 | |
| Natera (NTRA) | 2.5 | $14M | 62k | 229.09 | |
| Adaptive Biotechnologies Cor (ADPT) | 2.4 | $13M | 821k | 16.24 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.3 | $13M | 99k | 134.85 | |
| Supernus Pharmaceuticals (SUPN) | 2.3 | $13M | 258k | 49.70 | |
| Fractyl Health (GUTS) | 2.1 | $12M | 5.5M | 2.20 | |
| Mineralys Therapeutics (MLYS) | 2.1 | $12M | 332k | 36.29 | |
| Phathom Pharmaceuticals (PHAT) | 2.0 | $12M | 699k | 16.59 | |
| Adma Biologics (ADMA) | 1.8 | $10M | 565k | 18.24 | |
| Arcellx Common Stock (ACLX) | 1.8 | $10M | 156k | 65.20 | |
| Dyne Therapeutics (DYN) | 1.8 | $10M | 520k | 19.56 | |
| Disc Medicine (IRON) | 1.5 | $8.8M | 110k | 79.41 | |
| Ocular Therapeutix (OCUL) | 1.5 | $8.7M | 715k | 12.14 | |
| Septerna (SEPN) | 1.5 | $8.2M | 294k | 27.88 | |
| Protara Therapeutics Com Stk (TARA) | 1.4 | $7.7M | 1.4M | 5.33 | |
| Uniqure Nv SHS (QURE) | 1.2 | $6.9M | 288k | 23.93 | |
| Olema Pharmaceuticals (OLMA) | 1.2 | $6.7M | 267k | 25.00 | |
| Terns Pharmaceuticals (TERN) | 1.0 | $5.5M | 137k | 40.40 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $3.7M | 163k | 23.00 | |
| Heartflow Inc/Sh (HTFL) | 0.6 | $3.3M | 114k | 29.15 | |
| Grail (GRAL) | 0.5 | $2.6M | 30k | 85.59 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $2.3M | 201k | 11.31 | |
| Billiontoone Cl A (BLLN) | 0.4 | $2.1M | 26k | 81.84 | |
| Eledon Pharmaceuticals (ELDN) | 0.3 | $1.9M | 1.3M | 1.51 | |
| Hyperfine Com Cl A (HYPR) | 0.2 | $1.3M | 1.3M | 0.98 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.2 | $1.1M | 11k | 104.67 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.2 | $1.1M | 143k | 7.36 | |
| Metagenomi (MGX) | 0.2 | $857k | 529k | 1.62 | |
| Atai Beckley Nv SHS | 0.1 | $805k | 197k | 4.09 | |
| Outset Med Com New (OM) | 0.1 | $439k | 118k | 3.71 | |
| Sensei Biotherapeutics Com New (SNSE) | 0.0 | $157k | 15k | 10.67 |
